PARENTERALE FORMULIERUNGEN

European patent · EP3478266 · In force

Register entry

Publication number
EP3478266
Application number
EP17736733
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 29, 2017
Published
May 8, 2019
Granted
Jul 1, 2026
Protection ends at the latest
Jun 28, 2037
Next annual fee due
Jun 30, 2027
IPC classes
A61K 9/00 (2006.01)
A61K 31/353 (2006.01)
Priority
GB 201611545 01.07.2016
PCT application
PCT/GB2017/051913 29.06.2017
PCT publication
WO2018/002636 04.01.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 16, 2026

    Agent entered

    Representative
    HGF GmbH, OBC Suisse AG, Aeschengraben 29, 4051 Basel

    Published in Swissreg on 16.07.2026

  2. Jul 1, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 01.07.2026

Parties

Holder

Jazz Pharmaceuticals Research UK Limited

Building 730 Kent Science Park, Sittingbourne Kent ME9 8AG, GB

Agent

HGF GmbH

HGF GmbH OBC Suisse AG

Aeschengraben 29, 4051 Basel

Inventor

WRIGHT, Stephen

Sittingbourne Kent ME9 8AG, GB

WILKHU, Jitinder

Sittingbourne Kent ME9 8AG, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.